Skip to main content
Premium Trial:

Request an Annual Quote

BD Board Increases Dividend, Authorizes Share Repurchase

NEW YORK (GenomeWeb News) – Becton Dickinson today said that its board of directors has increased the quarterly dividend to $.37 per common share, up $.04 from the previous quarter.

Shareholders of record on Dec. 14 will be paid the dividend on Jan. 4, 2010, the firm said. BD said that the indicated annual dividend for fiscal 2010 is $1.48 per share.

In addition, BD's board authorized the repurchase of an additional 10 million common shares of the firm. This authorization is in addition to the roughly 7.6 million shares that remained available at Sept. 30 under a 10 million share repurchase authorization from November 2008.

As of Sep. 30, BD had approximately 237 million common shares outstanding.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.